UBS Group AG - MAIA BIOTECHNOLOGY INC ownership

MAIA BIOTECHNOLOGY INC's ticker is and the CUSIP is 552641102. A total of 10 filers reported holding MAIA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MAIA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$293
-97.9%
133
-96.6%
0.00%
Q1 2023$13,664
+28.5%
3,949
+30.3%
0.00%
Q4 2022$10,635
-29.1%
3,030
-34.0%
0.00%
Q3 2022$15,0004,5880.00%
Other shareholders
MAIA BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Centric Wealth Management 64,656$142,2430.06%
FNY Investment Advisers, LLC 17,550$380.02%
Naviter Wealth, LLC 22,168$48,7700.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 51,600$113,5200.00%
UBS Group AG 133$2930.00%
Sunbelt Securities, Inc. 50$1100.00%
WELLS FARGO & COMPANY/MN 63$1390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 44,557$98,0650.00%
MORGAN STANLEY 5,095$11,2090.00%
View complete list of MAIA BIOTECHNOLOGY INC shareholders